|
Type 1 Diabetes TrialNet is a network of 18 clinical centers dedicated to conducting diabetes prevention research and studying intervention therapies for children and adults with newly diagnosed diabetes. TrialNet centers work in cooperation with screening sites located throughout the United States, Canada, Europe and Australia/New Zealand. TrialNet researches are experts in both diabetes and the body’s immune system. They share common scientific goals related to the study, treatment, and prevention of type 1 diabetes.
|
